
Published
13 June 2011 | By Phenom World
In the pharmaceutical industry, pharmaceutical dosage forms are getting increasingly important as a basis for making more effective drugs. In the successful development of a new dosage form, formulation development typically plays a crucial role in the introduction and application of state of-the-art pharmaceutical technology. The manufacturability and/or bioavailability of many of these dosage forms regularly depend on the characteristics of the individual ingredients. It is for this reason, that it is extremely important that the bulk characteristics of so-called particulate systems such as powders and suspensions can be accurately monitored.
As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details
By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory
Fields marked * are compulsory